Simultaneous echocardiography and myocardial perfusion single photon emission computed tomography associated with dobutamine stress to predict long-term cardiac mortality in normotensive and hypertensive patients
Authors:
- Riccardo BigiRBRiccardo Bigi
- Jeroen J BaxJBJeroen J Bax
- Ron T van DomburgRDRon T van Domburg
- Abdou ElhendyAEAbdou Elhendy
- Lauro CortigianiLCLauro Cortigiani
- Arend Fl SchinkelASArend Fl Schinkel
- Cesare FiorentiniCFCesare Fiorentini
- Don PoldermansDPDon Poldermans
- 1 July 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (7) , 1409-1415
Abstract
Echocardiography and myocardial scintigraphy associated with dobutamine stress are used for assessing risk in coronary artery disease. We compared the accuracy of the two modalities applied simultaneously for predicting long-term cardiac mortality in normotensive and hypertensive patients. Three hundred and fifty-one consecutive patients underwent dobutamine stress with simultaneous echocardiography and 99mTc-sestamibi single photon emission computed tomography (SPECT). Fifty patients underwent early (<60 days) revascularization and were excluded; the analysis is based on 301 patients (131 hypertensives and 170 normotensives). The prevalence of additional risk factors, heart failure, prior myocardial infarction and prior revascularization was similar in the two groups of patients. An abnormal stress echocardiogram was detected in 101 (59%) normotensives and 80 (61%) hypertensives (NS), while 113 (66%) normotensives and 83 (63%) hypertensives (NS) showed abnormal myocardial perfusion. The agreement was 81% (kappa = 0.59) in hypertensives and 82% (kappa = 0.62) in normotensives. During 7.3 ± 2.8 years of follow-up, 17 (13%) hypertensives and 26 (15%) normotensives died from cardiac causes (P = 0.62). In normotensives, the annual mortality rate was 0.8 for normal echo and 1.3 for normal scan, 2.8 for abnormal echo and 2.6 for abnormal scan. In hypertensives, it was 0.5 for normal echo, 0% for normal scan, 2.6 for abnormal echo and 2.8 for abnormal scan. Each test was associated with higher survival in the case of negative compared to positive results in both normotensive and hypertensive patients (log-rank chi-square 16.4, P < 0.001). Dobutamine stress echocardiography and SPECT are equally effective in predicting long-term cardiac death in both normotensive and hypertensive patients.Keywords
This publication has 24 references indexed in Scilit:
- Clinical, exercise electrocardiographic, and pharmacologic stress echocardiographic findings for risk stratification of hypertensive patients with chest painThe American Journal of Cardiology, 2003
- Prediction of Outcomes in Hypertensive Patients With Suspected Coronary DiseaseHypertension, 2002
- Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise testJournal Of Hypertension, 2001
- Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise testJACC, 1999
- Dipyridamole Stress Echocardiography for Risk Stratification in Hypertensive Patients With Chest PainCirculation, 1998
- Long-Term Prognostic Value of Exercise Echocardiography Compared With Exercise 201 Tl, ECG, and Clinical Variables in Patients Evaluated for Coronary Artery DiseaseCirculation, 1998
- Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-photon emission tomography for the diagnosis of coronary artery disease in hypertensive patients with and without left ventricular hypertrophyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Cardiac Imaging for Risk Stratification With Dobutamine-Atropine Stress Testing in Patients With Chest PainCirculation, 1997
- ACC/AHA Guidelines for the Clinical Application of EchocardiographyCirculation, 1997
- The Heart in HypertensionNew England Journal of Medicine, 1992